(2S,4R)-4-[[2-[(1R,3R)-1-acetyloxy-3-[[(2S)-2-(3-tert-butyl-1-bicyclo[1.1.1]pentanyl)-2-[[(2R)-1-methylpiperidine-2-carbonyl]amino]acetyl]-methylamino]-4-methylpentyl]-1,3-thiazole-4-carbonyl]amino]-2-methyl-5-phenylpentanoic acid
C43H63N5O7S — CID 122521531
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S,4R)-4-[[2-[(1R,3R)-1-acetyloxy-3-[[(2S)-2-(3-tert-butyl-1-bicyclo[1.1.1]pentanyl)-2-[[(2R)-1-methylpiperidine-2-carbonyl]amino]acetyl]-methylamino]-4-methylpentyl]-1,3-thiazole-4-carbonyl]amino]-2-methyl-5-phenylpentanoic acid
(2S,4R)-4-[[2-[(1R,3R)-1-acetyloxy-3-[[(2S)-2-(3-tert-butyl-1-bicyclo[1.1.1]pentanyl)-2-[[(2R)-1-methylpiperidine-2-carbonyl]amino]acetyl]-methylamino]-4-methylpentyl]-1,3-thiazole-4-carbonyl]amino]-2-methyl-5-phenylpentanoic acid (PubChem CID 122521531) has the molecular formula C43H63N5O7S and a molecular weight of 794.07 g/mol. Its IUPAC name is (2S,4R)-4-[[2-[(1R,3R)-1-acetyloxy-3-[[(2S)-2-(3-tert-butyl-1-bicyclo[1.1.1]pentanyl)-2-[[(2R)-1-methylpiperidine-2-carbonyl]amino]acetyl]-methylamino]-4-methylpentyl]-1,3-thiazole-4-carbonyl]amino]-2-methyl-5-phenylpentanoic acid.
Molecular Properties
| Compound Name | (2S,4R)-4-[[2-[(1R,3R)-1-acetyloxy-3-[[(2S)-2-(3-tert-butyl-1-bicyclo[1.1.1]pentanyl)-2-[[(2R)-1-methylpiperidine-2-carbonyl]amino]acetyl]-methylamino]-4-methylpentyl]-1,3-thiazole-4-carbonyl]amino]-2-methyl-5-phenylpentanoic acid |
|---|---|
| PubChem CID | 122521531 |
| Molecular Formula | C43H63N5O7S |
| Molecular Weight | 794.07 g/mol |
| Exact Mass | 793.44 |
| IUPAC Name | (2S,4R)-4-[[2-[(1R,3R)-1-acetyloxy-3-[[(2S)-2-(3-tert-butyl-1-bicyclo[1.1.1]pentanyl)-2-[[(2R)-1-methylpiperidine-2-carbonyl]amino]acetyl]-methylamino]-4-methylpentyl]-1,3-thiazole-4-carbonyl]amino]-2-methyl-5-phenylpentanoic acid |
| SMILES | CC(=O)O[C@H](C[C@H](C(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H]1CCCCN1C)C12CC(C(C)(C)C)(C1)C2)c1nc(C(=O)N[C@@H](Cc2ccccc2)C[C@H](C)C(=O)O)cs1 |
| InChI | InChI=1S/C43H63N5O7S/c1-26(2)33(48(9)39(52)35(42-23-43(24-42,25-42)41(5,6)7)46-37(51)32-17-13-14-18-47(32)8)21-34(55-28(4)49)38-45-31(22-56-38)36(50)44-30(19-27(3)40(53)54)20-29-15-11-10-12-16-29/h10-12,15-16,22,26-27,30,32-35H,13-14,17-21,23-25H2,1-9H3,(H,44,50)(H,46,51)(H,53,54)/t27-,30+,32+,33+,34+,35+,42?,43?/m0/s1 |
| InChIKey | ZROWDDDFGZZAQQ-KADSANFVSA-N |
| XLogP | 6.26 |
| TPSA | 158.24 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 17 |
| Heavy Atoms | 56 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 794.07 |
| LogP ≤ 5 | 6.26 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122521531 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.